MPR Weekly Dose Podcast #157

Large recall of drugs due to company shutdown; First orally administered fecal microbiota treatment given green light; Treatment approved for certain ALS patients; Type 2 diabetes insulin delivery system; FDA issues safety alert concerning eyedrops.